Multiple Myeloma [MM] vs EHA
Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.
Multiple Myeloma [MM]
This clinical decision support tool provides healthcare professionals with curated, evidence-based medical content for managing Multiple Myeloma. It uses AI-powered natural language queries to deliver quick, confidence-rated answers, aiding in better patient care and outcomes.
- AI-powered natural language queries
- Evidence-based medical content
- Diagnosis, treatment, and care management topics
- Case studies, videos, and interviews
- Continuing medical education credit
- Patient education resources
Read full descriptionHide full description
@Point of Care™ With Cognitive AI is a clinical decision-making mobile platform. Multiple Myeloma @Point of Care™ provides a streamlined clinical decision support tool for clinicians to obtain content when it is needed—enabling better decisions, better outcomes, and better care. With Cognitive AI, clinicians use @Point of Care™ to easily access curated, evidence-based, and disease-specific medical content. Clinicians navigate content by asking voice-enabled natural language questions. With Cognitive AI, confidence-rated answers to efficiently incorporate best treatment options happen more quickly and decisions are made faster to improve patient outcomes at the point of care. Multiple Myeloma @Point of Care™ is designed to: • Support discovery and practice change • Provide relevant, evidence-based disease-specific medical content • Improve patient outcomes at the point of care Features: • Continually updated Multiple Myeloma content • Topics in diagnosis, treatment, and care management developed with expert physician authors • Case studies, videos, and interviews • Access to actionable patient-recorded data • Detailed reference list with access to original sources • Continuing medical education credit (CME/CE) • Surveys and peer polling • Patient education resources to share with patients
EHA
This app provides medical professionals, researchers, and scientists with the latest hematology news and updates. Access e-learning resources, stay informed about association meetings, and view recorded sessions from past congresses.
- Latest hematology news
- E-learning resource updates
- Information on EHA meetings
- Access to recorded congress sessions
- Virtual exhibit content
Read full descriptionHide full description
Welcome to the mobile app of the European Hematology Association (EHA). We are the leading European Association that brings together all medical professionals, researchers and scientists with a passion for hematology. Use this app to follow our latest hematology news, to receive updates about EHA e-learning resources and to stay tuned about EHA meetings. The 25th Annual Congress of EHA will take place from June 11-21, 2020 in a full virtual edition. With this app registered participants will have access to: - the EHA25 Virtual: Congress, June 11-14, 2020: Invited speakers, abstract presenters, Satellite Symposia and Updates-in-Hematology by pharmaceutical companies. - the EHA25 Virtual Thematic days, June 15-21, 2020: Overview sessions and special Q&A panel discussions. - the virtual exhibit with interesting content from our industry partners. - all recorded sessions and new content on-demand until October 15, 2020. Enjoy using the EHA app!
Screenshots
Verdict
The clearest difference is review sentiment: Multiple Myeloma [MM] at 50% against EHA's 0%. Multiple Myeloma [MM] also leads on rating (5.0 vs 2.3) and update cadence (every 5 weeks vs every 2 months). EHA's advantage is ratings volume (4 vs 1) and iOS requirement (11.0 vs 14.0). On price, ads, in-app purchases and monetization model there is nothing between them.
Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS
Both are free to download. Neither carries in-app purchases, so what you see is what you pay.
Multiple Myeloma [MM] holds the better App Store score, 5.0 against 2.3. Both are backed by a comparable volume of ratings — 1 and 4 respectively. Written reviews point the same way: 50% of Multiple Myeloma [MM]'s written reviews are positive against 0% of EHA's.
Multiple Myeloma [MM] ships an update every 5 weeks, EHA every 2 months. The most recent releases landed on October 5, 2026 and September 29, 2026 respectively.
| Parameter | Multiple Myeloma [MM] | EHA |
|---|---|---|
| Price | Free | Free |
| Rating | 5.0 (1 ratings) — better | 2.3 (4 ratings) |
| Positive reviews | 50.0% of reviews — better | 0.0% of reviews |
| Number of ratings | 1 | 4 — better |
| Update frequency | Every 5 weeks — better | Every 2 months |
| Ads | No | No |
| In-app purchases | No | No |
| Monetization | Free | Free |
| Devices | iPhone, iPad, iPod | iPhone, iPad, iPod |
| Requires iOS | 14.0 | 11.0 — better |
| Further details — not scored | ||
| Size | 24 MB | 48 MB |
| Age rating | 12+ | 12+ |
| Developer | @Point of Care | European Hematology Association |
Customer experience
Multiple Myeloma [MM]
EHA
In-app purchases
Multiple Myeloma [MM]
No in-app purchases
EHA
No in-app purchases
Questions
Is Multiple Myeloma [MM] free?
Is EHA free?
Which has better reviews, Multiple Myeloma [MM] or EHA?
Do Multiple Myeloma [MM] or EHA have ads?
Which is updated more often, Multiple Myeloma [MM] or EHA?
Other comparisons
![Multiple Myeloma [MM] Multiple Myeloma [MM]](https://cdn3.appshunter.io/i/Purple211/d26532b6e51d25357441a7554afcac41/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/512x0w.png)

![Multiple Myeloma [MM] Multiple Myeloma [MM]](https://cdn3.appshunter.io/i/Purple211/d26532b6e51d25357441a7554afcac41/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/512x0w.png)

![Multiple Myeloma [MM] Multiple Myeloma [MM]](https://cdn3.appshunter.io/i/Purple211/d26532b6e51d25357441a7554afcac41/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/512x0w.png)

![Multiple Myeloma [MM] Multiple Myeloma [MM]](https://cdn3.appshunter.io/i/Purple211/d26532b6e51d25357441a7554afcac41/AppIcon-0-0-1x_U007epad-0-11-0-85-220.png/512x0w.png)








